This report presents an overview of infectious diseases among people who inject drugs in Europe, both in the community and in prison settings, covering disease surveillance, outbreak investigations, and prevention and control, for the period up to the end of February 2019 (EMCDDA)
Bibliography: Interventions – Harm Reduction
ACMD: avoid Friday prison release to prevent drug relapse and deaths
Prison services could reduce drug-related harms by avoiding releasing vulnerable prisoners on a Friday, the ACMD has today advised the Home Secretary
ACMD report: Custody-community transitions
Report from the Advisory Council on the Misuse of Drugs (ACMD) on how to reduce drug-related harms that occur when people move between custody and the community
The Drugs Information and Monitoring System (DIMS)
Factsheet on drug checking in the Netherlands (Trimbos)
National intelligence network on drug health harms briefing: May 2019
This briefing is based on a meeting of the national intelligence network (NIN) on the health harms associated with drug use (Public Health England)
Allowing Pharmacists to Directly Dispense Opioid Antidote Can Sharply Cut Opioid Overdose Deaths
Allowing pharmacists to dispense the opioid antidote naloxone without a physician’s prescription can sharply reduce the incidence of fatal opioid-related overdoses, according to a new RAND Corporation study
Psychotropic Substances – Technical Report
On an annual basis the Psychotropics Control Section of the INCB Secretariat publishes a technical report that provides an overview of the world wide licit manufacture, export, import, stocks and consumption of substances controlled under the Convention on Psychotropic Substances of 1971 (INCB)
Withdrawal Management Services in Canada: The National Treatment Indicators Report (PDF)
The report provides an overview of the use of WM services in Canada in 2015–2016, including episodes of care offered within specialized community-based services and in hospitals (CCSA)
Health, rights and drugs (PDF)
Harm reduction, decriminalization and zero discrimination for people who use drugs (UNAIDS)
Promises to improve health outcomes for people who inject drugs remain unfulfilled as 99% do not have adequate access to harm reduction services
New report by UNAIDS highlights the urgent need to implement a human rights and evidence-informed approach to reach people who inject drugs with essential health service
Take-home Naloxone in England
Local Authority Survey (Release)
Widening the availability of naloxone
Explains regulations that widen the availability of naloxone, a drug used as an antidote for heroin (or other opiate) overdoses (Public Health England)
Survivors of Multiple Disadvantage Discuss Service & Support (PDF)
A report by Peer Researchers for the National Commission on Domestic and Sexual Violence and Multiple Disadvantage
Reformulation of OxyContin to Discourage Abuse Linked to Higher Rates of Hepatitis C Infections
Reformulation of the pain medicine OxyContin in 2010 to make it more difficult to abuse directly led to a large rise in hepatitis C infections as drug abusers switched from the prescription medication to injectable heroin, according to a new RAND Corporation study (RAND)
Statement from FDA Commissioner Scott Gottlieb, M.D., on unprecedented new efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths
With the number of overdose deaths involving prescription and illicit opioids more than doubling over the last seven years to nearly 48,000 in 2017, it’s critical that we continue to address this tragedy from all fronts. This includes new ways to increase availability of naloxone, a drug used to treat opioid overdose (FDA)
Prison health inquiry: government response
The government’s response to the Health and Social Care Committee’s inquiry into prison health (Department of Health and Social Care)
m-Health applications for responding to drug use and associated harms
This paper presents results from a scoping study on the availability of smartphone-based applications in the drugs field within a European and global context (EMCDDA)
Canadian Substance Use Costs and Harms in the Provinces and Territories (2007–2014) PDF
In June 2018, the Canadian Substance Use Costs and Harms Scientific Working Group released the results of a significant new study in a comprehensive technical report, Canadian Substance Use Costs and Harms (2007–2014). The report presents estimates of the economic costs and harms of substance use in Canada for the years 2007 to 2014
National intelligence network on drug health harms briefing: December 2018
This briefing is based on a meeting of the national intelligence network (NIN) on the health harms associated with drug use (PHE)
Just Maintaining the Status Quo?
The experience of long-term participants in Methadone Maintenance Treatment – PDF (dun Laoghaire rathdown drug and alcohol Task force)
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- …
- 24
- Next Page »